Vertex Pharmaceuticals, Inc. (VRTX)
476.90
+7.63
(+1.63%)
USD |
NASDAQ |
Feb 20, 16:00
476.85
-0.05
(-0.01%)
After-Hours: 20:00
Vertex Pharmaceuticals Market Cap : 121.15B for Feb. 20, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Moderna, Inc. | 19.49B |
| Gilead Sciences, Inc. | 187.84B |
| Eli Lilly & Co. | 952.34B |
| Merck & Co., Inc. | 303.45B |
| Pfizer Inc. | 151.52B |
Market Cap Related Metrics
| PE Ratio | 31.10 |
| PS Ratio | 10.19 |
| Price to Book Value | 6.490 |
| Price to Free Cash Flow | 38.53 |
| Price | 476.90 |
| Earnings Yield | 3.22% |
| Operating PE Ratio | 25.96 |
| Normalized PE Ratio | 28.43 |